z-logo
open-access-imgOpen Access
Leukocyte myeloperoxidase activity and serum CRP levels as predictive markers of inflammatory disorders amongst Passive smokers
Author(s) -
Reshma Kumarchandra,
Vinayak Bhandari,
U Prassanna,
S Akshatha,
M Moumitha,
S Ramya,
Shalini Srivastav,
Sourabh Shetty
Publication year - 2013
Publication title -
international journal of biomedical and advance research
Language(s) - English
Resource type - Journals
eISSN - 2455-0558
pISSN - 2229-3809
DOI - 10.7439/ijbar.v4i7.379
Subject(s) - medicine , myeloperoxidase , passive smoking , c reactive protein , odds ratio , lung cancer , tobacco smoke , inflammation , analysis of variance , immunology , gastroenterology , pathology , environmental health

Aims and objectives: To analyse the leukocyte myeloperoxidase activity and serum C-reactive protein levels in smokers, passive smokers and non-smokers and to evaluate the risk of developing inflammation that may lead to lung cancer in smokers in general and passive smokers in particular, by comparing the levels with nonsmokers

Methodology:.Study design comprised of three groups;active smokers(Smokers who have smoked more than 5 cigarettes/ day for a minimum period of 2 years.) passive smokers(Smokers exposed to smoke for a duration of >30 minutes/day, ≥5 days a week for one year or more (waiters in a pub/restaurant) and controls (non smokers). All patients with puemococcal infections were eliminated from the study .Leukocyte MPO & serum CRP (semiquantitative assay) were performed with patient s samples. Data was analysed by ANOVA followed by post hoc tests. Odds ratio was also calculated for the study groups.

Results: There was no significance in the study groups  with respect to both MPO as well as CRP.

Conclusion : CRP or MPO may not be the ideal  markers to predict the probability of developing an inflammatory disorder  in persons exposed to passive smoke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here